JRPMC Journal of Rangpur Medical College • Vol. 11 No. 1 (2026): March 2026 • Pages 105-110
Published: 2026-05-17 Open Access Original Article

Emerging Role of COL10A1 in Breast Cancer Pathogenesis and its Potential as a Clinical Biomarker

1.
Nilima Rani Roy
Assistant Professor, Department of Biochemistry, Prime Medical College, Rangpur
2.
Suraiya Pervin Narju
Associate Professor, Department of Physiology, Prime Medical College, Rangpur
3.
Farzana Hoque
Assistant Professor, Department of Anatomy, Prime Medical College, Rangpur
4.
Sanchita Barman
Senior Lecturer, Department of Biochemistry, Fazlur Rahman Medical College, Dhaka

Abstract

Background
Breast cancer is a leading malignancy worldwide, with high morbidity and mortality among women. Despite advances in therapy, metastasis, recurrence, and resistance remain challenges. Collagen type X alpha-1 (COL10A1) is normally expressed in cartilage but is increasingly implicated in tumorigenesis. Overexpression of COL10A1 in breast cancer correlates with higher grade, invasiveness, and poor prognosis.
Objective
To evaluate COL10A1 expression in breast cancer and its association with tumor characteristics, receptor status, and potential biomarker utility.
Methods
A hospital-based cross-sectional study was conducted at department of Surgery, Dhaka Medical College Hospital from July 2022 to June 2023, including 40 breast cancer patients. Data on demographics, clinical features, and reproductive history were collected, and tissue samples were analyzed for COL10A1 expression. Inclusion required histopathological confirmed breast cancer in women _40 years. Statistical analysis used SPSS for frequencies, percentages, means, and chi-square tests. Ethical approval and informed consent were obtained, ensuring confidentiality and voluntary participation.
Results
The study of 40 breast cancer patients revealed a mean age of 47.41 years. The majority had invasive ductal carcinoma (70%), Grade II (50%) or III (35%) tumors, and hormone-sensitive disease (60% ER-positive, 50% PR-positive). HER2-positivity was 25%. Critically, 80% exhibited moderate-to-high COL10A1 expression, which was strongly associated with high-grade tumors, as 10 of 14 Grade III patients showed high expression.
Conclusion
COL10A1 overexpression correlates with aggressive breast cancer, highlighting its potential as a prognostic biomarker.

J Rang Med Col.2026 Mar;11(1): 105-110

Keywords: Breast cancer COL10A1 Collagen type X alpha-1 Biomarker Tumor grade
Full-Text Downloads:
Open Access Article License